Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 220.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.77 | 52 Week High | $333.65 | |||
| Open | $220.77 | 52 Week Low | $223.02 | |||
| Day High | $220.77 | P/E | 28.27 | |||
| Day Low | $220.77 | EPS | $7.81 | |||
| Volume | 474 | |||||

